Sign in

CIK 0001855485 · <br>Emerging growth company

Calidi Biotherapeutics, Inc.

Sign in to watch
Tickers
CLDI CLDWW
Exchange
NYSE, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
862967193
Phone
858-794-9600
Business address
4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.

Securities

  • CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
  • CLDWW Common stock OTC
  1. 8-K Event Material agreement · Unregistered share sale
  2. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  3. 8-K Event Executive or director change
  4. 424B3 Offering Prospectus
  5. 8-K Event Executive or director change
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. DEF 14A Proxy Proxy Statement
  9. SCHEDULE 13D Stake Beneficial Ownership Report
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 4 Grant or award Director acquired 375,000 shares (grant or award)
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Material agreement · Regulation FD disclosure · Other events
  14. 8-K Event Material agreement
  15. 424B4 Offering Prospectus
  16. EFFECT Other Notice of Effectiveness
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. S-1/A Offering Registration Statement

Page 10 of 21 · 406 filings